Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

Iyza F. Baig

Advertisement

Articles by Iyza F. Baig

Grave’s disease

Considering use of teprotumumab in thyroid eye disease patients

ByAlexis Pascoe,Iyza F. Baig,Andrew G. Lee, MD
October 22nd 2018

There is need for alternative treatment to circumvent current treatment limitations

SLE

When autoimmune diseases exert neuro-ophthalmic effects

ByIyza F. Baig,Aroucha Vickers, DO,Andrew G. Lee, MD
September 25th 2018

Treatment should focus on the underlying etiology behind these processes

Exploring tocilizumab for giant cell arteritis cases

ByIyza F. Baig,Alexis Pascoe,Andrew G. Lee, MD
August 27th 2018
Advertisement

Latest Updated Articles

  • Exploring tocilizumab for giant cell arteritis cases
    Exploring tocilizumab for giant cell arteritis cases

    Published: August 27th 2018 | Updated:

  • SLE
    When autoimmune diseases exert neuro-ophthalmic effects

    Published: September 25th 2018 | Updated:

  • Grave’s disease
    Considering use of teprotumumab in thyroid eye disease patients

    Published: October 22nd 2018 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

Transformative advances in vision research: It’s the science

2

Pediatric and strabismus care: Evolving tools, emerging therapies

3

LASIK and beyond: Navigating the changing landscape of refractive surgery

4

What if? Ophthalmology without OCT – Part 5

5

Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us